|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smyth EC, Lagergren J, Fitzgerald RC,
Lordick F, Shah MA, Lagergren P and Cunningham D: Oesophageal
cancer. Nat Rev Dis Primers. 3:170482017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kato H and Nakajima M: Treatments for
esophageal cancer: A review. Gen Thorac Cardiovasc Surg.
61:330–335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiao R, Luo H, Xu W and Ge H: Immune
checkpoint inhibitors in esophageal squamous cell carcinoma:
Progress and opportunities. Onco Targets Ther. 12:6023–6032. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma X, Zhao W, Li B, Yu Y, Ma Y, Thomas M
and Zhang Y, Xiang J and Zhang Y: Neoadjuvant immune checkpoint
inhibitors plus chemotherapy in locally advanced esophageal
squamous cell carcinoma: Perioperative and survival outcomes. Front
Oncol. 12:8108982022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J,
Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, et
al: Esophageal and esophagogastric junction cancers, version
2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr
Canc Netw. 17:855–883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giganti F, Ambrosi A, Petrone MC, Canevari
C, Chiari D, Salerno A, Arcidiacono PG, Nicoletti R, Albarello L,
Mazza E, et al: Prospective comparison of MR with
diffusion-weighted imaging, endoscopic ultrasound, MDCT and
positron emission tomography-CT in the pre-operative staging of
oesophageal cancer: Results from a pilot study. Br J Radiol.
89:201600872016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ou J, Li R, Zeng R, Wu CQ, Chen Y, Chen
TW, Zhang XM, Wu L, Jiang Y, Yang JQ, et al: CT radiomic features
for predicting resectability of oesophageal squamous cell carcinoma
as given by feature analysis: A case control study. Cancer Imaging.
19:662019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Umeoka S, Koyama T, Togashi K, Saga T,
Watanabe G, Shimada Y and Imamura M: Esophageal cancer: Evaluation
with triple-phase dynamic CT-initial experience. Radiology.
239:777–783. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuriakose MA, Loree TR, Hicks WL, Welch
JJ, Wang H and DeLacure MD: Tumour volume estimated by computed
tomography as a predictive factor in carcinoma of the tongue. Br J
Oral Maxillofac Surg. 38:460–465. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li H, Chen TW, Li ZL, Zhang XM, Chen XL,
Wang LY, Zhou L, Li R, Li CP and Huang XH: Tumour size of
resectable oesophageal squamous cell carcinoma measured with
multidetector computed tomography for predicting regional lymph
node metastasis and N stage. Eur Radiol. 22:2487–2493. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li H, Chen TW, Zhang XM, Li ZL, Chen XL,
Tang HJ, Huang XH, Chen N, Yang Q and Hu JN: Computed tomography
scan as a tool to predict tumor T category in resectable esophageal
squamous cell carcinoma. Ann Thorac Surg. 95:1749–1755. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moss AA, Schnyder P, Thoeni RF and
Margulis AR: Esophageal carcinoma: Pretherapy staging by computed
tomography. AJR Am J Roentgenol. 136:1051–1056. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koo TK and Li MY: A guideline of selecting
and reporting intraclass correlation coefficients for reliability
research. J Chiropr Med. 15:155–163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu YP, Tang S, Tan BG, Yang LQ, Lu FL,
Chen TW, Ou J, Zhang XM, Gao D, Li KY, et al: Tumor stage-based
gross tumor volume of resectable esophageal squamous cell carcinoma
measured on CT: Association with early recurrence after
esophagectomy. Front Oncol. 11:7537972021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiao J, Qin J, Xing D, Li S and Wu D:
Diagnosis of retrolingual obstruction during drug-induced sleep
endoscopy versus polysomnography with nasopharyngeal tube in
patients with obstructive sleep apnea. Ann Otol Rhinol Laryngol.
130:1285–1291. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rice TW, Ishwaran H, Blackstone EH,
Hofstetter WL, Kelsen DP and Apperson-Hansen C; Worldwide
Esophageal Cancer Collaboration Investigators, : Recommendations
for clinical staging (cTNM) of cancer of the esophagus and
esophagogastric junction for the 8th edition AJCC/UICC staging
manuals. Dis Esophagus. 29:913–919. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Panebianco V, Grazhdani H, Iafrate F,
Petroni M, Anzidei M, Laghi A and Passariello R: 3D CT protocol in
the assessment of the esophageal neoplastic lesions: Can it improve
TNM staging? Eur Radiol. 16:414–421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi H, Zhang K, Niu ZX, Wang WP, Gao Q and
Chen LQ: Does tumour location influence postoperative long-term
survival in patients with oesophageal squamous cell carcinoma? Eur
J Cardiothorac Surg. 48:266–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rice TW, Rusch VW, Apperson-Hansen C,
Allen S, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE,
et al: Worldwide esophageal cancer collaboration. Dis Esophagus.
22:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kato H, Tachimori Y, Watanabe H, Yamaguchi
H, Ishikawa T and Kagami Y: Thoracic esophageal carcinoma above the
carina: A more formidable adversary? J Surg Oncol. 65:28–33. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuwano H, Nishimura Y, Oyama T, Kato H,
Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, et al:
Guidelines for diagnosis and treatment of carcinoma of the
esophagus April 2012 edited by the Japan esophageal society.
Esophagus. 12:1–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim S, Han K, Seo N, Kim HJ, Kim MJ, Koom
WS, Ahn JB and Lim JS: T2-weighted signal intensity-selected
volumetry for prediction of pathological complete response after
preoperative chemoradiotherapy in locally advanced rectal cancer.
Eur Radiol. 28:5231–5240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Q, Wan L, Zou S, Zhang C E T, Yang Y,
Ye F, Zhao X, Ouyang H and Zhang H: Prognostic risk factors and
survival models for T3 locally advanced rectal cancer: What can we
learn from the baseline MRI? Eur Radiol. 31:4739–4750. 2021.
View Article : Google Scholar : PubMed/NCBI
|
